A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation

類似資料

• Allogeneic GM-CSF Secreting Tumor Immunotherapy (GVAX(®)) Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility and Immune Activation
  著者:: Laheru, Dan, 等
  出版事項: (2008)
• Evaluation of Ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer
  著者:: Le, Dung T., 等
  出版事項: (2013)
• Development of a Cytokine-Modified Allogeneic Whole Cell Pancreatic Cancer Vaccine
  著者:: Laheru, Dan, 等
  出版事項: (2013)
• A Safety and Feasibility Study of an Allogeneic Colon Cancer Cell Vaccine Administered with a Granulocyte–Macrophage Colony Stimulating Factor–Producing Bystander Cell Line in Patients with Metastatic Colorectal Cancer
  著者:: Zheng, Lei, 等
  出版事項: (2014)
• Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
  著者:: Emens, Leisha A., 等
  出版事項: (2009)